In connection with modern trends related to the need to protect against infections and dosage of drugs, it is easy to predict that over time, the demand for pharmaceutical packaging will increase. It was recorded that in recent years, demand has increased by 5%. The reasons for this increase are different standards and strict rules regarding infection control, barrier protection, drug leakage, dosing, and patient compliance. These problems will further increase the need for high-quality accessories and packaging containers.
It was evident that pharmaceutical packages are currently gaining a significant market share, as is the case with pre-filled inhalers. An increase in the number of patients with allergies and asthma is the reason for this increase. Also, remarkable growth is expected in the case of prefilled syringes and vials due to changes associated with biotechnology. Innovations and treatments are also causing this growth.
Typically, KFM Co-Packer pharmaceutical packaging is in glass or plastic bottles. These bottles are commonly used to store capsules and tablets, weighing more than 50 grams. Among all types of packaging methods, blister packaging is gaining momentum due to its flexibility and enhanced labeling capabilities. However, topical medications will still be stored in the tube due to their aesthetic nature.
Pharmaceutical packaging for oral preparations will continue to be made in plastic or glass bottles. Also, plastic bottles are used to store capsules of more than 50 g and other medicines. Among them, the blister pack will gain momentum due to enhanced label content and its adaptability. Pharmaceutical packaging for topical drugs will remain in tubes due to their aesthetic and barrier properties.
Under the intense pressure of labeling and making more and more profit, KFM Co-Packer pharmaceutical packaging technologies are used by almost all small and large companies. The task of packaging and labeling is given priority in all cases since the cost of solving these problems can be very high.
Pharmaceutical packaging for oral preparations will continue to be made in plastic or glass bottles. Also, plastic bottles are used to store capsules of more than 50 g and other medicines. Among them, the blister pack will gain momentum due to enhanced label content and its adaptability. Pharmaceutical packaging for topical drugs will remain in tubes due to their aesthetic and barrier properties.
Under the intense pressure of marketing and profit, pharmaceutical packaging strategies will move the ship of large companies to small ones. In each case, due attention is paid to packaging and labeling, as the cost of the incorrect evaluation is very high.
It is essential to develop an effective packaging strategy for each pharmaceutical product. In this task, it is necessary to conduct an acute analysis of all critical factors. The following are some of the essential functions required to develop an effective strategy.
Identification of purchasing sectors and product supply chains.
Awareness of the latest technology and standards to improve quality and sales opportunities.
Search for the latest innovations available in the packaging industry.
They are focusing on labels, as customers primarily read them.